Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.025 USD | -1.37% | -0.50% | +21.14% |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Mar. 28 | Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | -1.37% | ||
1 week | -0.50% | ||
Current month | +4.70% | ||
1 month | +8.87% | ||
3 months | +25.35% | ||
6 months | +47.91% | ||
Current year | +21.14% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 9.025 | -1.37% | 5 650 |
24-05-03 | 9.15 | +0.55% | 1,381 |
24-05-02 | 9.1 | +1.17% | 1,691 |
24-05-01 | 8.995 | +4.35% | 4,707 |
24-04-30 | 8.62 | -4.96% | 21,601 |
Delayed Quote Nasdaq, May 06, 2024 at 02:35 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+21.14% | 16.67M | |
+22.15% | 47.9B | |
+46.56% | 41.42B | |
-2.41% | 40.7B | |
-6.20% | 28.92B | |
+10.75% | 25.55B | |
-21.14% | 19.27B | |
-1.54% | 12.15B | |
+31.19% | 12.14B | |
-0.36% | 11.99B |
- Stock Market
- Equities
- TLIS Stock